Semaglutide 2mg SM2 SM5 SM10 Lyophilized Powder free sample

Our peptide products are of high quality, available in stock, and we offer safe transportation services. We have over 200 types of peptide products to choose from, with our business expanding globally and our aim being to establish stable cooperative relationships.

Dosage: 2 milligrams, 5 milligrams, 10 milligrams, 20 milligrams, 30 milligrams, 40 milligrams, 50 milligrams, 60 milligrams, 100 milligrams. Small bottle of peptide.

Inventory: The inventory of best-selling products is sufficient and can be shipped immediately; custom orders are also accepted, including small bottle caps and larger doses.

Delivery time: UPS and Fedex shipping lines take 5-7 days. Dedicated express delivery takes 10-15 days. For countries with difficult customs clearance, the delivery period will be extended.

Peptide form: Freeze-dried powder

Peptide Package: 10 bottles per set
Peptide purity: 99%

WhatsApp：+852 5386 4749/+86 131 0329 5101

Email : postmaster999@gdxzh.com
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

Tirzepatide has a similar sequence to semaglutide, and the lys side chain in the sequence has PEG modification, which is the functional group of the polypeptide, and can increase the water solubility of the sequence. The main physiological function of Tirzepatide is glucose-dependent nutrition polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor double agonist, which is being developed for the treatment of type 2 diabetes and has entered the clinical stage.

Tirzepatide has been shown to help lose weight in overweight patients. Phase 3 clinical trials are currently underway for weight loss in adults who are overweight, obese, or have weight-related health issues. Tirzepatide has received FDA Fast Track designation to speed up its FDA application for treating adults with obesity, or who are overweight with weight-related health conditions.

Tirzepatide

CAS#: 2023788-19-2

Appearance: White Powder

Purity (HPLC): ≥99.0%

Single Impurity (HPLC): ≤1.0%

Sodium Content (HPLC): 5.0%-12.0%

Moisture Content (Karl Fischer): ≤10.0%

Peptide Content: ≥80.0%

Storage: Store at 2-8 degrees Celsius in a dry and cool place.

Packaging: 10mg, 20mg, 30mg, 40mg, 50mg, 60mg per box

Intended Use: For scientific research purposes

• Stable supply chain and reliable factory resources
• Strict quality control to ensure consistent product quality
• Competitive pricing with efficient production support
• Professional export experience and global market service
• Flexible cooperation models for different customer needs
We aim to build long-term partnerships by delivering quality products, dependable service, and sustainable cooperation.